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What is known about this topic: 
• Enuresis alarm therapy is first-line treatment for bedwetting. 
• Alarm failure is often linked to failure to wake to the alarm signal. 
What this study adds: 
• Rewarding recall of a personalised code word announced at the time of wetting can 
improve the arousal response and promote waking during alarm training. 
• Rewarding arousal rather than rewarding dry nights may result in greater reduction in 
wet nights with alarm training. 
• The code word alarm was found to be more effective than the control alarm in the 
children with monosymptomatic enuresis. 
 
  
  
 
 
ABSTRACT 
Objective: To compare a novel code-word alarm with a commercially available wireless 
alarm for treating enuresis 
Design: Randomised controlled trial with blinding of study personnel and outcome assessors 
Setting: A tertiary paediatric centre 
Patients: Children aged six to eighteen with at least three wet nights per week in the previous 
6 months referred by doctors 
Outcomes: Primary outcome: the proportion who achieved a full response (14 consecutive 
dry nights) by 16 weeks. Secondary outcomes: change in frequency of wetting, duration of 
alarm training, percentage of wet nights that the child woke to the alarm, adherence to 
treatment, adverse events and satisfaction with treatment. 
Results: Of the 353 participants, 176 were assigned to the code-word alarm and 177 to 
control. At 16 weeks, 54% (95% CI, 47% to 61%) in the experimental group and 47% (95% 
CI, 40% to 55%) in the control group had achieved a full response (p=0.22), with 74% and 
66% respectively attaining a 50% or more reduction in wetting frequency (p=0.14). The 
experimental group woke more often than the control group (median percentage of waking 
88% versus 77%, p=0.003) and had greater reduction in wet nights (median reduction 10 
versus 9 nights per fortnight). Fewer in the experimental group discontinued therapy before 
achieving a full response (27% versus 37% discontinued, p=0.04). There were no significant 
differences in relapse rates at 6 months, adverse events or satisfaction between the two 
alarms. In a post hoc subgroup analysis of children with monosymptomatic enuresis, more in 
the experimental group achieved a full response (66% versus 52%, p=0.047), with higher 
median percentage of waking (89% versus 79%, p=0.006) and greater reduction in wet nights 
(median reduction 12 versus 9 nights per fortnight).  
  
 
 
Conclusions: Although the code-word alarm increased waking, no difference in full response 
rates was demonstrated between the two alarms.   
  
 
 
INTRODUCTION 
Enuresis affects up to 20% of children
1
 and impacts on sleep, self-esteem and quality of life, 
which can be reversed with successful treatment
2-4
.  In enuresis, the normal arousal response 
to bladder distension is defective during sleep, with polysomnographic changes from deep to 
light sleep occurring without conscious awakening in many
5,6
. Alarm therapy, the first line 
treatment for enuresis
7
, conditions the child to wake to an auditory stimuli with wetting and 
either void in the toilet or inhibit voiding by contracting their urethral sphincter
8
, eventually 
learning to wake in response to bladder distension during sleep. Although this simple therapy 
is often effective, failure is common (25-35%)
7
, and thought to be due to failure to wake to 
the alarm or poor adherence to treatment. 
Although high sleep arousal thresholds is thought to be the reason why children fail to wake 
to the alarm, poor motivation to wake may also be a contributing factor. Motivation has been 
shown to enhance arousal to auditory stimuli during sleep in adults 
9
. We hypothesized that 
by producing a higher level of arousal during alarm training, the arousal response to bladder 
distension during sleep would improve resulting in better treatment outcomes. We designed 
an enuresis alarm that promotes waking by encouraging recall of a personalised code word 
and compared this with a commercially available enuresis alarm. 
METHODS 
Participants: Children aged six to 18 years with enuresis at least three nights per week in the 
preceding six months, who were referred by their family doctor or paediatrician to the study 
for alarm therapy were invited to participate. Children with monosymptomatic enuresis (night 
wetting only), non-monosymptomatic enuresis (night wetting with lower urinary tract 
symptoms) and those who had previously failed alarm training were included. Children with 
enuresis secondary to neurological or urological problems were excluded.  
  
 
 
Before enrolment, potential participants completed a 14-day bladder diary to determine 
eligibility and baseline measurements, and a questionnaire to identify demographic details, 
severity of wetting, type of enuresis (monosymptomatic or non-monosymptomatic) and 
previous treatments received. 
Study design: Participants were randomly assigned to either the code-word alarm or a 
commercially available wireless enuresis alarm. Treatment ceased after 16 weeks of alarm 
training or when the child achieved 14 consecutive dry nights (whichever came first), as 
recommended by the National Institute for Health and Care Excellence (NICE) Guidelines
10
. 
The randomisation sequence was computer generated and stratified according to gender and 
age by the method of minimization, and performed by an independent randomization service. 
Allocation occurred via a telephone call to the service, with investigators, clinicians and data 
analysts unaware of group assignment. Families were aware of their assigned alarm but were 
unaware which was the ‘novel’ arm because the control alarm was not commercially 
available in Australia at the time of the study and therefore both alarms looked unfamiliar. 
Interventions: The code-word alarm delivered a pre-recorded personalised code word when 
the child wet at night. Children were encouraged to remember the code word the next 
morning. We instructed the parents to reward recall, but did not specify what the reward 
should be. We hypothesised that a higher level of arousal is required for remembering and 
recalling a code word than from waking to the sound of the alarm, the standard method for 
arousal.  
The code-word alarm comprised of a wireless wetness sensor (secured in a pad worn inside 
the child’s underpants) and an alarm box (containing a digital voice recorder for parents to 
record personalised code words for their child) located beside the child’s bed. When wetting 
occurred, moisture was detected by the sensor and the alarm sounded. When the child woke 
  
 
 
and deactivated the alarm, the pre-recorded code word was announced and the child was 
encouraged by their parents to wake and void in the toilet. This code word changed daily.  
The control alarm was a wireless alarm that was commercially available in the United 
Kingdom at the time of the study (http://www.malemmedical.com/wireless-alarm-record-
wetness-sensor-and-toilet-trainer). The attachment of the sensor and location of the alarm box 
was similar to the experimental group. When wetting occurred, the alarm sounded with an 
identical noise to the code-word alarm, and the child was encouraged by their parents to wake 
and void in the toilet. However, there was no pre-recorded code word with the control alarm.  
To ensure the treatments received by both groups were as similar as possible, instructional 
DVDs with identical wording (apart from the instructions for setting the code word for the 
experimental alarm) were provided to families. 
Outcomes: Standardised outcomes were reported using the 2006 International Children’s 
Continence Society (ICCS) definitions 
11
. We compared frequency of wetting over 14 days at 
baseline with the end of treatment. In the original 2006 ICCS definition, a “full response” 
was defined as 14 consecutive dry nights (or completely dry), “response” as 90% to 99% 
reduction in enuresis compared with baseline,  “partial response” as 50 to 89% reduction and 
“nonresponse” as 0 to 49% reduction. We added a “worse” category for those whose wetting 
increased. Relapse was defined as more than one wet night per month after achieving full 
response and continued success was no relapse within 6 months of ceasing treatment.  
The ICCS definitions changed in 2014
12
 and we have also reported outcomes using these 
updated definitions as a sensitivity analysis. In the 2014 definitions, the term “full response” 
was changed to “complete response”, “partial response” was redefined as 50 to 99% 
reduction and “non-response” was less than 50% reduction in wetting compared with 
baseline. 
  
 
 
The primary outcome was the proportion of children who achieved full response (14 
consecutive dry nights) in the experimental and control groups by 16 weeks. Secondary 
outcomes were change in frequency of wetting over 14 nights, achieving more than 50% 
reduction in wetting compared with baseline, duration of alarm training, percentage of wet 
nights that the child woke to the alarm, adherence to treatment, discontinuation of alarm 
therapy before achieving a full response, adverse events and satisfaction with treatment by 
parents and children. We chose waking to the alarm as an outcome of interest as we wanted 
to assess whether improved waking will result in improved treatment outcomes. Waking was 
determined by diary records of the child being able to recall the code word the next morning 
in the experimental group and the child speaking to the parents when the alarm sounded for 
controls. Adherence to alarm training was measured as the percentage of nights on treatment 
that the child wore the alarm.  For those who chose to discontinue alarm training, the date 
they discontinued treatment was used as their end of treatment date. In those who achieved a 
full response, we also compared the time to achieve a full response and relapse within 6 
months of ceasing alarm training. The relapse rate was used to assess the sustainability of the 
alarm training after cessation of treatment.  
Follow up procedures: The study coordinator contacted participants bi-weekly during alarm 
training and bi-monthly after cessation of treatment for a total of 12 months from enrolment. 
Parents were requested to complete diaries recording treatment response and adherence to 
treatment during alarm training, and wet nights after cessation of treatment. Routine clinical 
care was provided after cessation of alarm training, including the use of medication or further 
alarm training as appropriate. 
Statistical methods: We aimed to recruit 320 children (160 in each study group), assuming a 
full response rate of 65% in the control group (as reported in previous studies)
7
, and 80% in 
  
 
 
the code-word alarm group (based upon single arm pilot data). This number would provide an 
80% power to detect a difference of at least 15%, with a two-sided type I error of 5% and 
assuming a non-adherence rate of 10%.  
We used an intention-to-treat approach and included patients who discontinued alarm training 
before achieving a full response in the denominator. Descriptive results were presented as 
frequencies and percentages for categorical variables and as medians and interquartile range 
(IQR) for continuous variables. In our primary analysis, we compared the proportion of 
children who attained a full response by 16 weeks in the experimental and control groups. 
The response of those who discontinued alarm therapy before achieving a full response and 
those who continued to wet at 16 weeks were derived from their treatment diaries as coded at 
the time of alarm discontinuation. The chi-squared statistic was used to test for a difference 
between proportions and the Mann-Whitney test applied to continuous variables, due to the 
skewness of their distribution. 
A follow-up relapse at 6 months was defined for a child if one or more bi-monthly contacts 
reported a relapse during that time period. If one or more bi-monthly contacts were missing, 
the relapse status at 6 months was based on the available contact information. We repeated 
the analysis on the subset of children who had complete information for all bi-monthly 
contacts as a sensitivity analysis and the results were similar. Although relapse at 12 months 
was an outcome initially planned in the protocol, the amount of missing data did not allow us 
to analyse it.  
As most previously published data on alarm therapy for enuresis was conducted in children 
with monosymptomatic enuresis (bedwetting only)
 7
, we conducted a post-hoc subgroup 
analysis of these patients. This population is known to be more responsive to alarm therapy 
and the subgroup analysis enabled our study to be compared with other studies of alarm 
  
 
 
therapy
7
. The subgroup analysis used the same methodology to compare primary and 
secondary outcomes across the trial arms. All reported p values were two-sided and the 
significance level was set at 0.05. 
The study was approved by The Children’s Hospital at Westmead Ethics Committee (Project 
Number 2007/063). Informed consent was obtained from participants and their parents. The 
study was funded by a National Health and Medical Research Council grant (Grant Number 
570761). The study was registered with The Australian New Zealand Clinical Trials Registry: 
(ACTRN12609000070235) 
https://www.anzctr.org.au/Trial/Registration/TrialReview.aspx?id=83457. All alarms used in 
the trial were purchased or built by the research team. 
RESULTS 
The study was conducted at the Children’s Hospital at Westmead, Sydney, Australia. Three 
hundred and fifty three children were enrolled in the study between May 2009 and December 
2010, with 176 allocated to the code-word alarm and 177 to the control alarm (Figure 1). 
There were two (1.1%) children lost to follow up in each arm. Although we were able to 
obtain information about their response at 16 weeks, we were unable to obtain diary data on 
other outcomes (Figure 1). 
Baseline characteristics were well matched, with the median age being 8.4 and 8.1 years, 62 
and 60% being male, 88 and 90% with primary enuresis and 56 and 57% with 
monosymptomatic enuresis for the experimental and control groups, respectively. Many had 
tried treatments previously, including alarm training in 10% experimental and 12% controls, 
desmopressin in 22% of both and tricyclic antidepressants in 5% and 4% respectively (Table 
1). As the treatment outcomes were similar between those with primary and secondary 
enuresis, we combined primary and secondary enuresis when reporting outcomes.  
  
 
 
Table 1: Characteristics of participants 
 
Code word  
Alarm 
Control 
Alarm 
 
N=176 (%) N=177 (%) 
Age (years)   
6-7  75 (43) 83 (47) 
8-9  55 (31) 47 (27) 
10-12  33 (19) 33 (19) 
13-18  13 (7) 14 (8) 
Male  109 (62) 107 (60) 
Primary enuresis  155 (88) 160 (90) 
Monosymptomatic  98 (56) 101 (57) 
Frequency of bedwetting *   
<1 per month 1 (1) 1 (1) 
       1-3 times per month 1 (1) 0 
       1-2 times per week 6 (3) 7 (4) 
       3-7 times per week 111 (63) 119 (67) 
      >once per night 55 (31) 50 (28) 
      Not sure 2 (1) 0 
Severity of bedwetting    
      Wet underpants 3 (2) 0 
      Wet pyjamas or nappies 121 (69) 125 (71) 
 Wet bed 52 (30) 52 (29) 
Previous treatment   
      Alarm 18 (10) 22 (12) 
     Desmopressin 39 (22) 39 (22) 
     Tricyclic antidepressants 8 (5) 7 (4) 
* All participants had at least 3 wet nights per week documented on their baseline bladder diary. However this table reports the frequency of 
bedwetting in the preceding 6 months as recorded on the demographic questionnaire, which differed from their baseline bladder diary
12 
 
 
 
Primary outcome:  
54% (95%CI, 47% to 61%) in the experimental group and 47% (95%CI, 40% to 55%) 
controls (p=0.22) achieved 14 consecutive dry nights by 16 weeks (Table 2). 
Secondary outcomes: 
Improvements in bedwetting: 74% (130/176) experimental versus 66% (118/177) 
controls attained 50% or more reduction in bedwetting at the end of alarm training 
(p=0.14), with 2% versus 4% achieving a response (90%-99% decrease in wetting), 
18% versus 15% a partial response (50-89% decrease in wetting), 24% versus 29% a 
nonresponse (0-49% decrease in wetting) and 2% versus 5% being worse. According 
to the 2014 ICCS definitions, 74% (130/176) in the experimental group versus 66% 
(118/177) controls had a complete or partial response, and 26% versus 34% 
respectively had a nonresponse (Table 2). The median reduction in wet nights was 10 
versus 9 nights per fortnight in the experimental and control groups respectively 
(p=0.029) (Table 3).  
Length of treatment: The median length of treatment was 54 days for the experimental 
group and 61 days for controls (p=0.72). The median time to achieve a full response 
(for those who became dry) was similar, with 46 versus 50 days respectively (p=0.98). 
Arousal response: The median percentage of wet nights the child woke to the alarm 
was 88% in the experimental group and 77% for controls (p=0.003) (Table 3 and 4).  
Adherence to alarm training: The percentage of nights during treatment that the child 
wore the alarm was similar between the two groups, with 91% experimental and 89% 
controls (p=0.32) (Table 3). Children who achieved a full response on average wore 
the alarm more consistently than those who did not achieve a full response (94% 
versus 86%, respectively, p<0.001).
13 
 
 
 
Table 2: Trial outcomes 
 
Code word 
Alarm 
Control 
Alarm p-value
†
 
N=176 N=177  
  n (%) n (%) 
 Primary outcome    
Full response  95 (54) 84 (47) 0.22 
    
Other categories of response*    
Response (90-99%) 4 (2) 7 (4) 
 Partial response (50-89%) 31 (18) 27 (15) 0.41 
No response (0-49%) 42 (24) 51 (29) 
 Worse (<0%) 4 (2) 8 (5) 
 *Categories or response according to ICCS definitions
11 Based on change in wetting at the end of treatment compared to baseline 
†Chi-square test comparing change in wetting from baseline between the two treatment groups. 
 
 
Table 2b: Outcomes of the code word and control arms according to 
2014 ICCS definitions
12 
 
Code word 
Alarm 
Control 
Alarm p-value
†
 
N=176 N=177  
  n (%) n (%) 
 Primary outcome    
Complete response  95 (54) 84 (47) 0.22 
    
Other categories of response*    
Partial response (50-99%) 35 (20) 34 (19) 0.32 
No response (<50%) 46 (26) 59 (34)  
*Categories or response according to the NEW ICCS definitions based on change in wetting at the end of treatment compared to 
baseline12  †Chi-square test comparing change in wetting from baseline between the two treatment groups. 
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Table 3: Secondary outcomes by treatment groups 
 
 
All patients  
(N=353)  
Monosymptomatic patients  
(N=199) 
 
Code word 
Alarm 
Control 
Alarm p-value  
Code word 
Alarm 
Control 
Alarm p-value  
  N=176 N=177 
 
N=98 N=101  
Secondary outcomes       
>50% improvement (%) 130 (74%) 118 (67%) 0.14
† 
 78 (80%) 72 (71%) 0.17
†
 
Reduction in wet nights, median (IQR) 10 (6-14) 9 (3-13) 0.029
‡
 12 (7-14) 9 (5-13) 0.010
‡
 
Length of treatment in days, median (IQR) 54 (34-100) 61 (37-97) 0.72
‡
 50 (31-83) 56 (36-99) 0.096
‡
 
Percentage of wet nights woke to alarm 
 - median % (IQR) 88 (63-100%) 77(56-93%) 0.003
‡
 89 (64-100%) 79(54-94%) 0.006
‡
 
Percentage of nights on treatment alarm worn         
- median % (IQR) 91 (34-100%) 89 (37- 97%) 0.32
‡
 94 (79-98%) 89 (72-98%) 0.27
‡
 
Chose to stop (%) 48 (27%) 66(37%) 0.044
†
 22 (22%) 31 (31%) 0.19
†
 
Any relapse in 6 months* (%) 62 (67%) 51 (62%) 0.50
†
 40 (63%) 38 (58%) 0.53
†
 
Adverse reactions (%) 30 (17%) 39 (22%) 0.24
†
 2 (2%) 5 (5%) 0.45
†
 
Time to achieve full response* - median (IQR) 46 (34-68) 50 (32-65) 0.98
‡
 44 (33-60) 45 (30-64) 0.97
‡
 
IQR - Interquartile range; *Only for whose who achieved a full reponse; † Chi-square test; ‡ Mann-Whitney test 
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Table 4: Percentage of nights child woke to alarm by trial arm and response 
categories according to ICCS (International Children’s Continence Society)10 by 
trial arm 
 
Code word 
Alarm 
Control 
Alarm p-value
†
 
N=176 N=177  
 
Median % of 
nights (IQR) 
Median % of 
nights (IQR) 
 
ICCS categories of response*    
Full response (100%) 93 (75-100) 82 (63-97) 0.003 
Response (90-99%) 52 (30-72) 58 (38-75) 0.93 
Partial response (50-89%) 82 (62-98) 71 (55-86) 0.22 
No response (0-49%) 67 (41-88) 72 (31-93) 0.69 
Worse (<0%) 76 (48-88) 31 (4-92) 0.41 
IQR - interquartile range; *Based on percentage of improvement; † Mann-Whitney test 
 
Attitude to alarm training: 48/176 (27%) in the experimental group and 66/177 (37%) 
controls chose to discontinue training within the 16 week treatment period before 
achieving 14 consecutive dry nights because they did not like training (p=0.044). 
Adverse effects were similar between groups (14% versus 16% respectively) (Table 
3). The most commonly reported adverse effect was sleep disturbance (14 versus 17). 
Other reported adverse effects included the child being frightened by the alarm (2 
versus 4) and alarm training triggering sleepwalking and nightmares (1 in each 
group). Overall, most children (90% versus 86%) and families (95% versus 93%) 
reported being happy with the treatment received. 
Relapse: Relapse rates assessed at 6 months after cessation of alarm training were 
similar in the two arms, with 67% of those who had achieved a full response in the 
experimental group and 62% in the control group reporting relapse (p=0.50) (Table 
3). 
Subgroup analysis of children with monosymptomatic enuresis:  
There were 199 children with monosymptomatic enuresis, with 98 allocated to the 
code-word alarm and 101 to the control alarm (Figure 1). Of those with 
16 
 
 
 
monosymptomatic enuresis, 66% (65/98) in the experimental group versus 52% 
(53/101) controls achieved full response by 16 weeks (p=0.047).  
The median reduction in wet nights was greater in the code-word alarm group, with 
12 nights reduction per fortnight versus 9 nights compared with baseline (p=0.01). 
The median percentage of wet nights the child woke to the alarm was also higher for 
the experimental group, with 89% versus 79% of wet nights waking (p=0.006). The 
median length of treatment and the relapse rates at 6 months were similar in the two 
arms (Table 3). 
DISCUSSION 
In our study the full response rate was not higher for the code-word alarm group than 
controls for the whole cohort, although there was a small but significant reduction in 
the median number of wet nights (10 versus 9 nights per fortnight) and increase in 
median percentage of wet nights the child woke to the alarm (88% versus 77%) 
favouring the code-word alarm. We propose that the inclusion of participants who had 
non-monosymptomatic enuresis (who may or may not have received treatments for 
their lower urinary tract symptoms), those who had previous failed treatment, as well 
as those who chose to stop alarm training before achieving a full response contributed 
to the lack of difference seen between the two groups. Children with non-
monosymptomatic enuresis are more likely to have multiple episodes of wetting at 
night compared with the monosymptomatic group, which would make alarm training 
more difficult and may result in desensitisation to the alarm. We included these 
children in our study for ethical reasons because they represent a typical clinical 
population who commonly use alarm therapy. 
This is the largest study of alarm therapy for treating enuresis, and one of the few 
head to head studies comparing a novel alarm with the best current treatment
7
. 
17 
 
 
 
Interestingly Van Londen’s paper demonstrated that immediately rewarding the child 
for correct behaviour at the time of waking was more effective than delayed rewards 
for dry nights the following day, and that both were better than receiving no reward
13
.  
In our study, we found that delayed reward for recall of the code word (which 
required increased arousal at the time of wetting) was better than delayed reward for 
dry nights, suggesting that rewarding correct behaviour is better than rewarding for a 
desired outcome. The cost of the two alarms used in our study is very similar.  
Limitations of this study include that it was not powered to adequately address the 
large proportion of children with non-monosymptomatic enuresis
14
, which was double 
the expected in the population, possibly due to the setting of a tertiary paediatric 
centre with more complex referrals
14
. Another limitation was our choice of a full 
response as the primary outcome which may have been too stringent, as clinically 
significant differences in other outcomes may have been missed.  
The overrepresentation of children with non-monosymptomatic enuresis in our study 
is likely to bias our study towards the null. Hence, we conducted a post-hoc subgroup 
analysis of the monosymptomatic group, as most published studies of alarm therapy 
including the Cochrane systematic review
7
 predominantly included children with 
monosymptomatic enuresis. Our post-hoc analysis found a significant difference in 
full response rate, median reduction in wet nights and median percentage of wet 
nights the child woke to the alarm suggesting that the code-word alarm is more 
effective than the control alarm in monosymptomatic enuresis. These results are 
consistent with what was found in the Cochrane review
7
. However, as this analysis 
was conducted post-hoc, these results should be interpreted with caution.  
CONCLUSIONS 
18 
 
 
 
The findings from our study have implications for clinicians who treat children with 
nocturnal enuresis. The focus of alarm training has traditionally been on achieving 
night dryness. Encouraging parents to reward arousal (rather than rewarding dry 
nights) when their child is alarm training is relatively simple and is likely to be 
associated with a reduction in wet nights, although this may not necessarily lead to 
complete resolution of wetting. 
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